These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 18261250)

  • 1. Decrease in REM latency and changes in sleep quality parallel serotonergic damage and recovery after MDMA: a longitudinal study over 180 days.
    Kirilly E; Molnar E; Balogh B; Kantor S; Hansson SR; Palkovits M; Bagdy G
    Int J Neuropsychopharmacol; 2008 Sep; 11(6):795-809. PubMed ID: 18261250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term neuronal damage and recovery after a single dose of MDMA: expression and distribution of serotonin transporter in the rat brain.
    Kirilly E
    Neuropsychopharmacol Hung; 2010 Sep; 12(3):413-23. PubMed ID: 20962361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDMA treatment 6 months earlier attenuates the effects of CP-94,253, a 5-HT1B receptor agonist, on motor control but not sleep inhibition.
    Gyongyosi N; Balogh B; Kirilly E; Kitka T; Kantor S; Bagdy G
    Brain Res; 2008 Sep; 1231():34-46. PubMed ID: 18638459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single dose of MDMA causes extensive decrement of serotoninergic fibre density without blockage of the fast axonal transport in Dark Agouti rat brain and spinal cord.
    Kovács GG; Andó RD; Adori C; Kirilly E; Benedek A; Palkovits M; Bagdy G
    Neuropathol Appl Neurobiol; 2007 Apr; 33(2):193-203. PubMed ID: 17359360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated BDNF protein level in cortex but not in hippocampus of MDMA-treated Dark Agouti rats: a potential link to the long-term recovery of serotonergic axons.
    Adori C; Andó RD; Ferrington L; Szekeres M; Vas S; Kelly PA; Hunyady L; Bagdy G
    Neurosci Lett; 2010 Jul; 478(2):56-60. PubMed ID: 20435092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
    Jaehne EJ; Majumder I; Salem A; Irvine RJ
    Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroanatomic specificity and time course of alterations in rat brain serotonergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine): assessment using quantitative autoradiography.
    Battaglia G; Sharkey J; Kuhar MJ; de Souza EB
    Synapse; 1991 Aug; 8(4):249-60. PubMed ID: 1681594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
    Adori C; Andó RD; Kovács GG; Bagdy G
    J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose MDMA does not result in long-term changes in impulsivity in the rat.
    Saadat KS; Elliott JM; Green AR; Moran PM
    Psychopharmacology (Berl); 2006 Sep; 188(1):75-83. PubMed ID: 16896956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
    Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats.
    Meyer JS; Grande M; Johnson K; Ali SF
    Int J Dev Neurosci; 2004; 22(5-6):261-71. PubMed ID: 15380826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
    Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
    Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of MDMA ("ecstasy")-induced neurotoxicity to long-lasting psychomotor stimulation in mice.
    Itzhak Y; Ali SF; Achat CN; Anderson KL
    Psychopharmacology (Berl); 2003 Mar; 166(3):241-8. PubMed ID: 12590354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
    García-Osta A; Del Río J; Frechilla D
    Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
    Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
    Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.